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We showed previously that the activity of 3-hydroxy-3-
methylglutaryl coenzyme A (HMG CoA) reductase, the 
rate-limiting enzyme of cholesterol biosynthesis, increases 
after both barrier disruption with organic solvents and in 
essential fatty acid deficiency (EFAD). Here, we treated 
EFAD hairless mice with linoleic acid, columbinic acid 
(C18: 3,n-6, trans; not metabolizable to known regulatory 
eicosanoids), prostaglandin E2 (PGE2), or latex occlusion, and 
determined transepidermal water loss (TEWL), epidermal 
protein content, and epidermal HMG CoA reductase activ-
ity. Increased TEWL rates in EF AD were accompanied by 
increased HMG CoA reductase activity (+ 130%, n = 6, 
P < 0.01) and protein content (+69%; n = 6, P < 0.025). 
Artificial restoration of the barrier by occlusion reduced the 
increase in enzyme activity and protein content toward nor-
mal, but barrier function, measured immediately after re-
moval of the latex wrap, deteriorated further (TEWL: tWO-
fold greater than EFAD unoccluded; p < 0.01). Topical ap-
plications of either linoleate or columbinate (but not PG~2) ' 
normalized barrier function, HMG CoA reductase actiVIt}', 
and protein content. These results show that a) barrier.funer tion modulates HMG CoA reductase activity; b) reduction 0 
cholesterol synthesis with occl usion results in a further deteri-
oration in barrier function, suggesting that increased synthe-
sis is a protective homeostatic response; and c) the barfler 
abnormality reflects a requirement for specific fatty acids for 
the barrier rather than resulting from epidermal hyperplasli 
or decreased prostaglandin generation. ] Invest Dent1ato 
99:216-220, 1992 
---------------------------------------------------------------------------------------------------------
Prior studies have shown that essential fatty acid defi-ciency (EFAD) results in chronic barrier disruption, as measured by excess transepidermal water 1055 (reviewed in [1- 3]) . This chronic barrier abnormality is associated with epidermal hyperplasia and increased DNA synthe-
sis [4,5) . The essential component missing from a EFAD-diet has 
been identified as linoleic acid [3,6,7) and either topical or systemic 
administration of linoleic acid restores barrier function and norma-
lizes transepidermal water 1055 (TEWL). The defective barrier in 
EFAD-animals is attributable to substitution of oleate for linoleate 
in O-acylsphingolipids [6). Most epidermallinoleate is ester-linked 
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Abbreviations: 
OTT: dithiotreitol 
EDTA: ethylenediamine tetra acetic acid 
EFAD: essential fatty acid deficiency 
HMG CoA: 3-hydroxy-3-methylglutaryl coenzyme A (reductase) 
PBS: (Dulbecco's) phosphate-buffered saline 
PGE2: prostaglandin E2 
SDS: sodium-dodecyl sulfate 
TEWL: transepidermal water loss 
to omega-hydroxy-acids, which in turn are amide-linked to sphi~­
gosine (ceramide I) [6,7). It has been suggested that this molecule IJ 
critical for lamellar bilayer formation in the stratum corneum, a~ 
hence for maintenance of the permeability barrier [6,7) . It has a s~ 
been demonstrated that linoleic acid normalizes the increased DN 
synthesis and thereby reverses epidermal hyperplasia [4,5). We re-
cently have shown [5) that epidermal DNA synthesis is regulated fY 
barrier function, suggesting that in EFDA the epidermal hyperf. a- . 
sia may be a physiologic attempt to repair the disturbed permeab1htY 
barrier. ( 
The mechanism by which EFAD and linoleate replenishmel1 
affect DNA synthesis and epidermal hyperplasia is not fully under-
stood. Linoleate is a precursor of arachidonic acid, which in turn IS d 
precursor for the production of prostaglandins, prostacyclines, ~ 
the thromboxanes by the fatty acid cyclooxygenase system [8]. It as 
been reported that topical applications of prostaglandin E2 allevl~te 
skin scaliness and hyperplasia in EFA deficient rat paws [9) , but thl: 
treatment does not restore barrier function [3,10-12). It also ~ 
been reported that this treatment does not alleviate scaliness (I~ 
shaved EFAD rats [12). In contrast, columbinic acid [C18 : 3,~_ 
6,9, 13-trans)), which is not metabolized to prostaglandin E2, refor Is 
edly rerairs the epidermal barrier abnormality in EFAD anUpa e 
[12 -16J. Barrier repair occurs over both cyclo- and lipOxygen~l. 
blockade, where regulatory eicosanoids are not generated [3, 17:Je
r
_ 
EFAD affects not only epidermal DNA synthesis but also er1 Js 
mal lipid synthesis. Prior studies have shown that in EFAD anIma 11 
the synthesis of both cholesterol and free fatty acids is increased, ~ 
alteration that is reversed when the barrier is artificially restored ~ 
occlusion [19). The relationship to the permeability barrier Via 
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fU~ther supported by the fact that acute barrier disruption in hairless 
rnlce also results in an increase in cholesterol and fatty aCld synthesIs 
[20], which parallels the barrier abnormality [21]. 
The enzyme, HMG CoA reductase catalyzes the conver.sion of 
HMG CoA to mevalonic acid and in mammalian systems, mclud-
ing the epidermis it is rate limit'ing for cholesterol biosynthesis 
[22,23]. We recen~ly have shown that HMG CoA reducta~e activ.ity 
Increases following pertubation of the permeability barner, an m-
crease again prevented by latex occlusion [23,24] . These resul.ts 
demonstrate that in the epidermis, as in other tissues, alter.atlOns m 
cholesterol content are primarily modulated via changes m HMG 
eoA reductase activity. . 
Th.e purpose of this study was to examin~ the role of barner 
fUnction versus hyperplasia in regulati~g epld~rmal HMG eoA 
redu~tase activity. We treated EFAD ammals W.lt~ latex occlUSIOn 
Or With selected fatty acids (linoleic acid, columbmlc aCld, or prosta-
glandlll E2) and determined barrier function, protem content, a?-d 
HMG CoA reductase activity. Our results demonstrate that ~arner 
requirements regulate HMG CoA reductase in EFAD ammals. 
Moreover, prolonged occlusion, which suppresses HMG C?A r~­
ductase, provokes a further deterioration in barner functlOn.m ~FAD animals. Finally,.we have shown ~hat the ba~ner abnorm.ahty 
n.EFAD reflects a reqUirement for speClfic fatty aClds m the eplder-
rniS. 
MATERIALS AND METHODS 
Materials Radioisotopes, i.e., (14C)HMG CoA (54.2 mC~/ 
nrnol), (3H)mevalonic acid (300 Ci/nmol), (14C)acetate (57.5 UCI/ frnol), and eH)mevalonolactone (38.8 Ci/nmol) were purchased 
rom .New England Nuclear (Boston, MA). 
Anion exchange resin (AG l-X8, formate form, 200-400 mesh 
styre~e-divinyl benzene matrix) was purchased from BIO-Rad Labo-
ratones (Richmond, CA). EDTA, glucose-6-phosphate, glucose~6-
rhosphate dehydrogenase (400 U /mg protein), NADP, and dltiu?-
reltol (DTT) were purchased from Sigma Chemical Co. (St. LOUIS, ~O). Hairless male weanling mice (HR/HR) aged 19-21. d, and 
elghing 6 - 12 g, were purchased from] ackson Laboratones (B~r ~arbor, ME). The animals were divided into two gro~ps and k~pt m 
~acent cages on a normal light cycle room m the ammal faClhty at 
the Veterans Administration Medical Center, San FranCISco. Con-
trol animals were fed a diet consisting of casein, sucrose, choline, a 
rnlJeture of salt, fat-soluble vitamins A, D, E, and water-soluble B 
Vitamins to which 5% corn oil and inositol (1 mg/g) was added, 
h'hereas the EFAD group received an identical diet, exce~t that 5% 
Y?rogenated coconut oil was substituted for the corn 011 (source: ~Iliiarns MA, Tinow ], I:Iinz~nbergs], !homas B, Department of 
Utntlonal Sciences UmvefSlty of Callforma, Berkeley). TEWL ~as rneasured weekl~. Mice were maintained on an EFAD diet [2] 
Or 7 -8 weeks until TEWL levels were over 10 g/m2/h. Replen-
Ished anirnals were also fed the EFAD diet, supplemented with corn 
all (50% linoleic acid) 4 d before the study, ad libidum. 
MethOds To assess directly the effect of occlusion, which in-~ I d . nt Y lowers TEWL rates to zero, groups of EFAD-treate mice 
were covered with a tightly fitted, water-impermeable membrane ~ole finger of a latex glove) for 3 d until just before the ammalswere 
I led. TEWL was measured in ether-anesthetized animals under 
arnbie.nt atrnospheric condition, in the morning with a Meeco elec-
tr.cIYtlc Water analyzer (Warrington, PA) [25]. "Ultrapure" dry ~tro~en gas (99.99%) was passed through the ~ample cup at 100 
Irnl.n. The sampling cup was separated from ItS Parafilm cover, 
and shd onto the site to be measured, thus minimizing exposure to 
atrnospheric humidity. Contralateral sites were measured on each ~~I~al t.o ensure the reproducibility of the TEWL measurements. 
W In pnor studies on EFAD rodents [5,22,23,26,27], TEWL rates 
ere Virtually identical over all sites on each animal, although there 
was Co 'd bl . I . I . . o nSl era e am rna -to-amma vanatlon. . 
h celuslOn of animal skin with a latex wrap for 3 d re.s~l~s m 
hyperhydration of the stratum corneum, which leads to an Imtlally 
Igh rate of water loss from the skin immediately after removal of 
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the wrap as the excess water is lo~t from the stratum ~orneum. 
Therefore, the wrap is removed 5 mm pnor to the determmatlon of 
TEWL to allow evaporation of excess water. It takes another 5 min 
to measure TEWL by the Meeco electronic water analyzer. During 
this time additional excess water is removed by a stream dry of 
nitrogen gas that passes through the sample cup and .the water 
analyzer. Measurement is finished after the steady state IS reached, 
which reflects the actual TEWL [25]. 
Topical Applications of Columbinic Acid and Prostaglandi: E2 :. In 
these experiments, one side of the defiCient al11ma~s ~ 6 cn: ) rec~lved 
once daily applications over 5 d of 30 ILl columbmlc aCld (a gift of 
U .M.T. Houtsmuller, Univerlever Ltd., The Netherlands) or pros-
taglandin E2 (both as methyl esters, 5 mg/l00 Ill) in propylene 
glycol: ethanol (7: 3 v Iv). Care was taken to ensure that t~e s?lu-
tions were spread evenly and did not run. TEWL determmatlons 
were made prior to the oil applications. 
Tissue Preparation for Enzyme Assay: Mice were killed by cervical 
dislocation, and the skin was excised and immediately placed epider-
mis-side downward onto a covered petri dish containing crushed 
ice. The undersurface of the skin pieces was scraped with a sharp 
scalpel blade (number 15) to re.move. excess ~ubcutaneous fat. Epide.r-
mis was separated from dermiS by Immersion m 10 rnM EDTA m 
Ca- and Mg-free PBS, at 37"C for 40 min. After treatment, the 
epidermis was peeled o~ the dermis in one piece by ~ently scraping 
with a scalpel blade, dned on paper.towels, mmc.ed m small pl~ces 
« 1 mm3) with scissors, and stored m small plastic tubes overmght 
at-70°C. 
Microsomal Isolation and Enzyme Assay: Four volumes ofhomogen-
ization buffer (0.3 M sucrose, 10 rnM mercaptoethanol, 10 rnM 
EDTA, sodium salt, and 50 rnM sodium chloride, pH 7.4) were 
added to the minced tissue at 4 ° C. Each tissue was subjected to two 
separate bursts with a tissue homogenizer (Polytron PCU ? Kine.m-
tatic GmbH, Lucerne, Switzerland) for 20 seconds at 80% mtenslty. 
A 20-second pause between t~e ~ursts was eJ?ployed. to permit 
cooling of the tissue . Homogeruzatlon was contlllued With a FI~her 
Sonic Dismembranator (model 300, Artec Systems Corp., Farmmg-
dale, NY) at 35% intensity, two times for 5 seconds with a pause of 
20 seconds. The homogenate was filtered through surgical gauze 
soaked in the homogenization buffer, and then centrifuged in a 
microfuge (TM 11, Beckman Instruments, Inc., Fullerton, CA) at 
800 X g for 15 min. The pellet was washed with one volum.e of 
homogenization buffer and recentrifuged at 800 X g for 15 mm. 
The pooled supernatants then were centrifuged in a microfuge at 
10,000 X g for 15 min. The 10,000 X g supernatant was then. cen-
trifuged at 100,000 X g for 60 min in a LB-70 M ultracentnfuge 
using a 50.3 TI-rotor (Beckman Instruments, Inc.). The supe~natant 
was removed and the microsomal pellet was stored overrught at 
-70°C. 
For the enzyme and the protein assay, the microsomal pellet was 
resolubilized in a solution containing 20 rnM imidazol and 5 mM 
DTT. HMG CoA reductase activity was determined, as described 
previously [23]. HMG CoA reductase ac~ivity was exp:essed as nan-
omoles of mevalonate synthesized per mmute per milligram of pro-
tein. 
Protein Assay: The protein amount was determined with a. ~io­
Rad Laboratories Protein Assay dye reagent [26]. The resolublhzed 
microsomal pellet contained both soluble and insoluble protein. 
The Bio-Rad Protein Assay quantitates only soluble protein ([26], 
Bio-Rad protein assay manual instruction). We used the same ho-
mogenization, centrifugation and resolubilization procedures in 
every experiment; the soluble in proportion to insoluble protein did 
not show significant variations. Therefore, we quantified only solu-
ble protein in epidermal samples. 
Statistical Analysis Statistical significance was determined 
using a two-tailed Student t test. When samples were compared 
from the same animal, significance was determined using a paired t 
test. 
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Figure 1. TEWL in EFAD. EFAD hairless mice were treated with lino-
leate, columbinate, prostaglandin E2 , or latex occlusion. TEWL was mea-
sured with a Meeco electronic water analyzer (n = 3 - 6, data are mean ± 
SEM 'p < 0.01 versus EFAD, +p < 0.01 versus control). 
RESULTS 
Effects of Topical Lipids and Occlusion on Barrier Func-
tion We first measured TEWL as a marker of barrier function 
(Fig 1). In these studies, the essential fatty acid deficient animals 
demonstrated TEWL rates that were greater than 10.0 (mean 
20.8 ± 3.0) g/m2/h. Use of either !inoleate replenishment or topi-
cal columbinic acid for 5 d reduced the elevated TEWL rates toward 
normal levels (3.0 ± 0.61, n = 3, P < 0.01 and 3.84 ± 0.3 g/m2/h, 
n = 3, P < 0.01, respectively). In contrast, topical treatment of 
EFAD animals with prostaglandin E2 (PGE2) or the vehicle alone 
did not significantly affectTEWL (19.45 ± 4.35, n = 3, not signifi-
cant and 22.02 ± 4.54 g/m2/h, n = 3, not significant, respec-
tively). Providing an artificial barrier by prolonged occlusion with a 
latex wrap for 3 d resulted in a further increase in TEWL rates, 
immediately after removal of the occlusive membrane (48.73 ± 
4.55 g/m2/h, n = 5, P < 0.005) respectively. These measurements 
indicate that the disturbed permeability barrier in EFAD mice is 
restored by either linoleate or columbinate replenishment, whereas 
PGE2 does not repair the barrier. Moreover, prolonged latex occlu-
sion causes a further deterioration in barrier function. 
Protein Content in Treated Versus Untreated EFAD Anim-
als Epidermal hyperplasia and increased DNA synthesis are well 
known features of EFAD animals. In a previous publication, we 
measured DNA synthesis after !inoleate replenishment, topical co-
lumbinic acid and prostaglandin E2 treatment, and latex occlusion, 
and observed that the restored barrier function (occlusion, colum-
binic acid, or !inoleate) returned DNA synthesis toward normal, 
whereas PGE2 had no significant effects [5]. Here, we determined 
protein content as a further marker of epidermal hyperplasia in a 
parallel cohort of animals ' (Fig 2). In EFAD, there was a 69% in-
crease in epidermal protein content in comparison to normal mice 
(EFAD, 35.1 ± 2.4, versus normal, 20.8 ± 1.6 j1g/cm2, n = 5, P < 
0.005). Linoleate replenishment and topical columbinic acid treat-
ment, which repaired barrier function, reduced the quantity of pro-
tein toward normal values (24.2 ± 2.1, n = 3, P < 0.025 and 
17.5 ± 1.6 j1g/cm2, n = 3, P < 0.005, respectively). In contrast, 
vehicle and prostaglandin E2 treatment did not significantly alter 
protein content (33.8 ± 3.6, n = 3, not significant, and 32.2 ± 3.1 
j1g/cm2, n = 3, not significant, respectively). Finally, prolonged 
occlusion with a latex wrap for 3 d markedly reduced the protein 
content (25.7 ± 1.7 j1g/cm2, n = 3, P < 0.025). These results show 
that linoleate replenishment, topical treatment with columbinic 
acid, and prolonged occlusion all markedly reduce epidermal pro-
tein content, a marker of hyperplasia in EFAD mice, whereas prosta-
glandin E2 was not effective. 
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HMG CoA Reductase Activity in Treated Versus Untreat~d 
Animals We next determined HMG CoA reductase activity tn 
EFAD animals treated as above. The data are expressed both as total 
enzyme activity (per cm2) and as enzyme-specific activity (per mg 
protein) (Fig 3). Total enzyme activity in EFAD mice was increaset 
130% in comparison to control (EFAD, 49.8 ± 2.2; contro, 
21.6 ± 1.6 pmoljmin/cm2, n = 6, P < 0.01). Latex occlusion for 
3 d markedly reduced the increased enzyme activity (29.8 ± 2.~ 
pmoljmin/cm2, n = 3, P < 0.005). Linoleate replenishment an 
topical columbinate also reduced enzyme total activity (Iinoleate; 
27.0 ± 4.8, n = 3, P < 0.025; columbinate, 17.0 ± 0.6 pmol/mtn 
cm2, n = 3, P < 0.001. In contrast, only a small decrease (not statiS-
tically significant) was seen after prostaglandin E2 treatment 
(40.2 ± 2.4 pmoljmin/cm2, n = 3, not significant). The results, 
expressed as the specific activity of HMG CoA reductase in the 
entire epidermis in EFAD, were similar to the total activity values, 
but the differences were smaller (Fig 3B versus 3A). InEFAD eplde~­
mis, HMG CoA reductase specific activity was increased 37% I~ 
comparison to normal (EFAD, 1.42 ± 0.06; control, 1.04 ± 0.0 d 
nmoljmin/mg protein, n = 6, P < 0.025). Latex occlusion for 3 
markedly reduced enzyme-specific activity (1.16 ± 0.05 nrn,ol/ 
min/mg protein, n = 5, P < 0.025). Both orallinoleate replenish-
ment and topical columbinate also reduced HMG CoA specific ac~ 
tivity toward normal (Iinoleate, 1.11 ± 0.07, n = 3, P < 0.02~ 
columbinate, 0.97 ± 0.07 nmol/min/mg protein, n = 3, E 
0.025). In contrast, prostaglandin E2 did not significantly affe~ 
enzyme-specific activity (1.25 + 0.09 nmoljmin/mg protein, n-
3, not significant). These results demonstrate that barrier restora-
tion and reversal of hyperplasia by occlusion, linoleate, and columi 
binate markedly reduces the increase in HMG CoA reductase tota 
and specific activity. In contrast, prostaglandin E2, which did not 
restore barrier function or reverse hyperplasia, does not influence 
enzyme activity. 
DISCUSSION 
Role of Cholesterol and Fatty Acids in the Barrier Previo~S 
studies from our laboratory have shown that there is a relationshT 
between barrier function and epidermal cholesterol synthesis, mo G 
ulated by the rate-limiting enzyme of cholesterol synthesis, J-:lM . 
CoA reductase activity (reviewed in [27]). When barrier functIOn IS 
acutely disturbed with either acetone or sodium-dodecyl sulfate 
(SDS), epidermal cholesterol synthesis and HMG CoA reduct~se . 
activity both increase. Moreover, artificial restoration of the b.arrled 
by occlusion prevents the increase in both cholesterol syntheSIS an . 
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Figure 2. Protein content in EFAD. EFAD hairless mice were treated ~ 
described in Fig 1. The skin was excised and epidermis was separated froi!1 dermis by the ED~A method . . After homo?enization, epidermal prod:ta 
content was determmed as described mMatenals and Methods (n = 3- 6'1) 
are mean ± SEM, 'p < 0.025 versus EFAD, +p < 0.025 versuS contro . 
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p' h~~lre 3 .. HMG CoA reductase total and specific activity in EFAD: EFAD 
epl~ ess mice were treated as described in Fig 1. The skin was eXCised and 
gel .errrus was separated from dermis by the EDTA method. After homo-
M nlZ~tlon HMG CoA reductase activity was determined as described in 
c~;r~als and Methods. :rotal activity (A) was expressed per surface area (per 
are nd specific activity (B) was expressed per mg protem. (n = 3 - 6, data 
mean ± SEM, .p < 0.025 versus EFAD, +p < 0.025 versus control). 
~nzYrne activity [19,23,24] . We also have shown that cholesterol 
bYn~hesls is increased in EFAD, a condition that is associated with 
~\ han abnormality in barrier function [2,3,20,23,24] and epider-
~ Y,Perplasia [4,5]. 
b arner dysfunction and epidermal hyperplasia are well-known, 
r~ separate abnormalities of the EFAD state. Because HMG CoA 
v Uctase activity is increased by 130% when expressed per cm2, 
ieersus only 37% when expressed per milligram protein (these stud-
cas abd [24]), about one third of the increase in enzyme total activity th n d e related to the abnormality in barrier function whereas two Thr s can be attributed to the hyperplasia associated with EFAD. 
Cr IS conclusion is supported by our prior findings of an 83% in-
[s e~;e In c~IO.lesterol synthesis and a 50% increase in DNA synthesis 
b
a
' . ]. ThiS IS consistent with a requirement for cholesterol for both 
br rner (intercellular lipid enriched bilayers) and new cell mem-:Uls, secondary to increased cell turnover. 
ered b treatments that restored barrier function in EFAD also low-
li loth the total and the specific activity ofHMG CoA reductase. 
fu no ~ate replenishment and topical columbinate restored barrier 
pr~ctlon and returned enzyme activity to normal levels. In contrast, 
lowstaglandlU E2 , which did not repair barrier function, also did not 
rep er HMG CoA reductase activity, consistant with its inability to 
sio air ~he barrier [15] . After artificial barrier repair by latex occlu-
res~i ~G CoA reductase activity was markedly reduced. This 
ted In a striking deterioration in barrier function, suggesting 
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that the increased HMG CoA reductase activity in EFAD is a com-
pensatory response designed to repair barrier function. The link 
between barrier repair and lipid synthesis also has been demon-
strated in prior studies. a) The increase in enzyme activity and lipid 
synthesis after acute barrier disruption by acetone treatment is pre-
vented by latex occlusion. This inhibition of lipid synthesis prevents 
the characteristic recovery of barrier function [19 ,23,24,28]. b) Ap-
plication of the HMG CoA reductase inhibitor lovastatin after ace-
tone treatment delays barrier repair [29]. 
How essential fatty acids and selected derivates, such as colum-
binic acid, function in EFAD is not known. Summarizing studies 
from the laboratories of Houtsmuller, Needleman, and Ziboh, 18-
or 20-carbon fatty acids with the linoleic acid structure (that means 
with cis double bonds between carbons 9 and 10 and carbons 12 and 
13 (n-6,9 cis double bands) are able to normalize the skin in EFAD 
mice [12,13,16,30]. According to Houtsmuller and van der Beck, 
even-numbered fatty acids with n = 6,9 cis double bands are active, 
and this includes C14 : 2. Odd carbon fatty acids (C19 and C21) 
were also active if double bonds were in n-5,8 or in n-7, 10 position 
[12]. Additional double bonds at the carboxyl end of the carbon 
chain also influenced activity in EFAD animals [13]. In a series of 
C18 and C20 fatty acids with cis or trans double bonds in position 
from delta-2 to delta-6, in addition to the linoleic acid configura-
tion, all showed some ability to correct the barrier. But' only 
gamma-linolenic acid [C18: 3(n-6,9,12-cis)] and columbinic acid 
[C18: 3(n-6,9,13-trans)] were as effective as linoleic acid [12-16] . 
Even the 12-trans or 13-cis compounds were considerably less active 
[13] . 
Alternatively, oxidized metabolites of linoleic acid and colum-
binic acid could be important for skin repair in EFAD. A (n-6) 
lipoxygenase can transform linoleic, gamma-linolenic, and col um-
binic acid into the corresponding 13-hydroxy unsaturated fatty 
acids [30 - 36]. It was shown that the lipoxygenase product of co-
lumbinic acid is capable of producing nearly as much resolution of 
the scaly dermatitis in EFAD rats as the fatty acid itself, whereas 
cyclooxygenase products were not effective [30] . If these 13-hy-
droxy unsaturated fatty acids have a special function in the regula-
tion of differentiation, or if they possess structural function in acyl 
ceramide and/or acids, is currently unknown [30-36]. 
Relationship of Barrier Function to Epidermal Hyperplasia: In a 
previous study, we showed that DNA synthesis and epidermal hy-
perplasia also are linked to barrier function [5]. Acute barrier disrup-
tion by acetone treatment or tape-stripping stimulates DNA synthe-
sis leading to epidermal hyperplasia. Artificial barrier repair by latex 
occlusion immediately after acetone treatment or tape-stripping 
prevents both the increase in DNA synthesis and epidermal hyper-
plasia. In addition, occlusion also normalizes the rates of DNA 
synthesis in EFAD animals, despite the presence of an ongoing 
deficiency state. These findings led us to hypothesize that the in-
crease in DNA synthesis leading to epidermal hyperplasia in EFAD 
may be an attempt to repair the disturbed permeability barrier [5]. 
This conclusion is supported by recent measurements of changes in 
HMG CoA reductase activity in EFAD animals in different epider-
mal cell layers. Whereas enzyme total activity was increased in all 
nucleated layers, the increase in enzyme-specific activity was re-
stricted to the upper epidermis (granular layers) . In contrast, the 
increase in enzyme total activity in the lower epidermis was related 
to epidermal hyperplasia [24] . Here, we provide further evidence 
linking barrier function to hyperplasia. All factors that improved 
barrier function also reversed epidermal hyperplas ia. Thus, latex 
occlusion, as well as both linoleate and columbinate replenishment, 
also reduced DNA synthesis, protein content, and epidermal hyper-
plasia, whereas PGE2 , which did not restore barrier function, also 
did not influence these parameters. 
The link between HMG CoA reductase activity and DNA synthe-
sis is well established. HMG eoA reductase regulates the biosynthe-
sis of mevalonate, whose immediate isoprenoid products include 
farnesylated proteins, such as Ras oncogenes and lamin B, which are 
involved in growth control (reviewed in [37]) . Moreover, the most 
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distal lipid product of HMG CoA reductase, cholesterol, is also 
required for cell replication [37]. Therefore, epidermal barrier func-
tion could regulate HMG CoA reductase activity both directly and 
as a consequence of the barrier-induced alterations in DNA synthe-
sis. Columbinic acid (not metabolizable to prostaglandin E2, while 
simultaneously repairing barrier function) normalized HMG CoA 
reductase activity and reversed epidermal hyperplasia, whereas pros-
taglandin E2 did not have significant effects on barrier function, 
enzyme activity, or hyperplasia. This clearly shows that the normali-
zation of skin function in EFAD mice is independent of prostaglan-
din E2 generation, and suggests instead that correction of the barrier 
alone is sufficient to normalize epidermal lipid synthesis and hyper-
plasia. 
In summary, these results show in EFAD animals that a) barrier 
function modulates HMG CoA reduction activity and cholesterol 
synthesis in EFAD animals; b) reduction of cholesterol, protein, and 
DNA synthesis by latex occlusion results in a further deterioration 
in barrier function, suggesting that the increases in synthesis are a 
protective, homeostatic response; and finally, c) that the barrier 
abnormality in EFAD reflects a requirement for specific fatty acids 
for the barrier, and is due neither to epidermal hyperplasia nor to 
decreased prostaglandin generation. 
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